Stefano Zanigni

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial.

Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial.

Journal: The Lancet. Neurology

Published: December 18, 2025

Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment.

Cost-Effectiveness Modelling of Multiple System Atrophy for Early Health Technology Assessment.

Journal: PharmacoEconomics - open

Published: August 20, 2025

Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part III.

Estimation of and clinical consensus on the meaningful motor progression threshold on MDS-UPDRS Part III.

Journal: Journal of Parkinson's disease

Published: February 20, 2025

Trial of Prasinezumab in Early-Stage Parkinson's Disease.

Trial of Prasinezumab in Early-Stage Parkinson's Disease.

Journal: The New England journal of medicine

Published: August 03, 2022

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study.

Treatment of withdrawal headache in patients with medication overuse headache: a pilot study.

Journal: The journal of headache and pain

Published: March 22, 2017

Mitochondrial dysfunction in myotonic dystrophy type 1.

Mitochondrial dysfunction in myotonic dystrophy type 1.

Journal: Neuromuscular disorders : NMD

Published: March 12, 2017

Brain structural profile of multiple system atrophy patients with cognitive impairment.

Brain structural profile of multiple system atrophy patients with cognitive impairment.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: September 25, 2016

White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.

White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.

Journal: Parkinsonism & related disorders

Published: September 09, 2016

Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.

Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.

Journal: Journal of molecular neuroscience : MN

Published: September 07, 2016

Precuneal Thickness and Depression in Parkinson Disease.

Precuneal Thickness and Depression in Parkinson Disease.

Journal: Neuro-degenerative diseases

Published: July 05, 2016

Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.

Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.

Journal: European radiology

Published: June 18, 2016

Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes.

Recurrent De Novo and Biallelic Variation of ATAD3A, Encoding a Mitochondrial Membrane Protein, Results in Distinct Neurological Syndromes.

Journal: American journal of human genetics

Published: June 06, 2016

Showing 1-12 of 28

Last Updated: 09/26/2026